Ironwood Pharmaceuticals Inc (IRWD)
3.44
+0.10
(+2.99%)
USD |
NASDAQ |
Nov 22, 16:00
3.42
-0.02
(-0.58%)
After-Hours: 20:00
Ironwood Pharmaceuticals Market Cap: 550.50M for Nov. 22, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 22, 2024 | 550.50M |
| November 21, 2024 | 534.49M |
| November 20, 2024 | 563.30M |
| November 19, 2024 | 609.71M |
| November 18, 2024 | 643.31M |
| November 15, 2024 | 673.72M |
| November 14, 2024 | 657.72M |
| November 13, 2024 | 688.92M |
| November 12, 2024 | 703.32M |
| November 11, 2024 | 764.94M |
| November 08, 2024 | 793.74M |
| November 07, 2024 | 745.73M |
| November 06, 2024 | 806.54M |
| November 05, 2024 | 718.53M |
| November 04, 2024 | 670.52M |
| November 01, 2024 | 670.52M |
| October 31, 2024 | 632.11M |
| October 30, 2024 | 664.07M |
| October 29, 2024 | 680.07M |
| October 28, 2024 | 664.07M |
| October 25, 2024 | 633.66M |
| October 24, 2024 | 636.86M |
| October 23, 2024 | 636.86M |
| October 22, 2024 | 652.86M |
| October 21, 2024 | 670.47M |
| Date | Value |
|---|---|
| October 18, 2024 | 704.07M |
| October 17, 2024 | 710.47M |
| October 16, 2024 | 720.07M |
| October 15, 2024 | 702.47M |
| October 14, 2024 | 686.47M |
| October 11, 2024 | 681.67M |
| October 10, 2024 | 673.67M |
| October 09, 2024 | 673.67M |
| October 08, 2024 | 664.07M |
| October 07, 2024 | 641.66M |
| October 04, 2024 | 688.07M |
| October 03, 2024 | 676.87M |
| October 02, 2024 | 681.67M |
| October 01, 2024 | 643.26M |
| September 30, 2024 | 659.27M |
| September 27, 2024 | 642.15M |
| September 26, 2024 | 648.54M |
| September 25, 2024 | 627.77M |
| September 24, 2024 | 642.15M |
| September 23, 2024 | 651.74M |
| September 20, 2024 | 686.88M |
| September 19, 2024 | 720.42M |
| September 18, 2024 | 722.02M |
| September 17, 2024 | 715.63M |
| September 16, 2024 | 714.03M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
534.49M
Minimum
Nov 21 2024
2.418B
Maximum
Feb 14 2024
1.657B
Average
1.717B
Median
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 3.327M |
| Palatin Technologies Inc | 18.77M |
| iBio Inc | 24.15M |
| Theriva Biologics Inc | 3.562M |
| Oragenics Inc | 3.346M |
Market Cap Related Metrics
| PS Ratio | 1.438 |
| Price to Free Cash Flow | 4.396 |
| Price | 3.44 |
| Earnings Yield | -0.87% |
| Operating PE Ratio | 5.070 |
| Normalized PE Ratio | 312.76 |